ICON completes ClinicalRM acquisition

By Melissa Fassbender contact

- Last updated on GMT

Icon’s acquisition of Clinical Research Management (ClinicalRM) expands its presence in the government sponsored research market. (Image: iStock/BernardaSv)
Icon’s acquisition of Clinical Research Management (ClinicalRM) expands its presence in the government sponsored research market. (Image: iStock/BernardaSv)

Related tags: Vaccine

The acquisition, which was announced in June of this year, has been completed, expanding the company’s reach into government sponsored research.

As Outsourcing-Pharma.com previously reported​, the acquisition of Clinical Research Management, Inc. (ClinicalRM) expands Icon’s presence in the government sponsored research market.

The announcement secures a new line of customers for the company and extends its capabilities in the areas of vaccines and infectious disease.

Commenting on the completed acquisition, ICON’s CEO, Ciaran Murray said, “ClinicalRM has a strong track record of partnering successfully with government agencies and NGOs​.”

Murray added that the company will provide a platform for Icon to further penetrate this market segment as the company works to grow and diversify its customer base.

ClinicalRM’s work in the area of global vaccine development will further enhance our capabilities in this important area to the benefit of customers and patients globally​,” he said in the company's press release published this morning.

Icon did not respond to a request for additional comment.

Related news

Show more

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 20-Jun-2022 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Governing and Maintaining Clinical Data Standards

Governing and Maintaining Clinical Data Standards

Veeva | 10-May-2022 | Technical / White Paper

Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...

What the Best Clinical Study Build Pros Do

What the Best Clinical Study Build Pros Do

Formedix | 09-May-2022 | Technical / White Paper

Getting your clinical study designed and built ready for data collection takes A LOT of work and expertise… you've got to do all your CRF designs;...

Related suppliers

Follow us

Products

View more

Webinars